Intrinsiqq
TuHURA Biosciences, Inc. logo

TuHURA Biosciences, Inc.

HURA

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$82M
EPS-$0.51
P/E-2.47
P/FCF-3.45
EV/EBITDA–
FCF Yield–
Div. Yield–
Net Debt/FCF-0.3x
TuHURA Biosciences, Inc. intrinsic value
52-Week Range
$0.44$3.15

Profitability & Returns

Revenue (FY)

$0.00

Net Income (TTM)

-$30M

▼ -38.6% YoY

Op. Margin

–

ROIC

–

Cash Flow & Balance Sheet

FCF (TTM)

-$24M

▼ -87.4% YoY

Op. Cash Flow (TTM)

-$24M

▼ -87.6% YoY

Net Debt

$8M

Cash & Equiv.

$2M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with HURA

CompareIntrinsic value
VRCAVerrica Pharmaceuticals Inc.
$2.74-5.03%40
VYNEVyne Therapeutics Inc.
$12.90-9.35%36
TVRDCara Therapeutics Inc.
$0.99+4.55%20
AARDAardvark Therapeutics, Inc.
$0.92-7.74%10
SLNSilence Therapeutics plc
$19.81+0.00%10
BIOEBio Essence Corp
$0.47+0.00%55
BOLTBolt Biotherapeutics Inc.
$4.91-2.96%15
CVSICV Sciences, Inc.
$0.01-2.00%25

Held by ETFs

HURA is in 1 US ETF. The largest of them, with HURA's weight in each:

TuHURA Biosciences (HURA) in three numbers

Quality score
0/100
Best check: share count change, 28840662.3%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-2.47
Negative: a loss over the last twelve months. Price to free cash flow -3.45.
Financials

Questions about TuHURA Biosciences

Is TuHURA Biosciences a high-quality business?

TuHURA Biosciences scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is share count change at 28840662.3%. The Quality tab shows every check against its target.

Does TuHURA Biosciences (HURA) pay a dividend?

No. TuHURA Biosciences (HURA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 10 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in HURA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HURA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.